Annex Advisory Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
PR
SGH
YLHM
Annex Advisory Services's XBI Position: Q3 2026 in Review
Annex Advisory Services increased its State Street SPDR S&P Biotech ETF (XBI) stake by 4.6% in Q3 2026, buying an estimated $1.85M and bringing the position to 266,485 shares worth $42M. The position accounts for 0.69% of the portfolio, ranked #47.
Annex Advisory Services first reported a position in XBI in Q1 2026 and has held it in 3 quarters since. 327 funds tracked by Wall St. Rank hold XBI as of Q3 2026.
- Annex Advisory Services held 266,485 shares of State Street SPDR S&P Biotech ETF worth $42M as of Q3 2026.
- Annex Advisory Services bought 11,723 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $1.85M.
- State Street SPDR S&P Biotech ETF made up 0.69% of Annex Advisory Services's portfolio in Q3 2026, its #47 holding.
- Annex Advisory Services first reported a position in State Street SPDR S&P Biotech ETF in Q1 2026 and has held it in 3 quarters since.
- 327 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.
Based on Annex Advisory Services's 13F filing for Q3 2026, filed 16 Oct 2026.